Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Moderna (MRNA) Is Up 10.1% After Unanimous FDA Panel Backing For mRNA Flu Shot mFlusiva
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
RNA Therapeutics Market Set to Nearly Triple by 2034 as Regulatory Approvals and Pandemic Preparedness Drive Adoption
Moderna (MRNA) Stock Could Be 39% Overvalued After FDA Flu Vaccine Backing
Biotech Stocks Worth Watching - June 21st
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Moderna (MRNA)
Analysts Conflicted on These Healthcare Names: AbbVie (ABBV) and Moderna (MRNA)
Moderna (MRNA) Receives Unanimous FDA Panel Support for Flu Vaccine
Dianthus Therapeutics (NASDAQ:DNTH) vs. Moderna (NASDAQ:MRNA) Financial Analysis - Markets Daily
Moderna, Inc. (NASDAQ:MRNA) Given Consensus Rating of "Reduce" by Analysts - Zolmax
What Roivant Sciences (ROIV)'s $2.25 Billion Moderna Settlement and Immunology Wins Mean For Shareholders - Simply Wall St News
Moderna, Inc. $MRNA Shares Sold by Tobam
Promising Biotech Stocks To Follow Today - June 19th - Stock Observer
Roivant Sciences (ROIV) Stock Could Be 19.5% Undervalued After Moderna Settlement And Pipeline Progress
Hamilton Wealth LLC Acquires New Stake in Moderna, Inc. $MRNA
Stephen Hoge Sells 53,336 Shares of Moderna (NASDAQ:MRNA) Stock - Markets Daily
FDA Advisors Support Moderna's mRNA Flu Vaccine for Adults 50 and Older, ETPharma
FDA committee recommends a new mRNA flu vaccine : NPR
FDA panel recommends mRNA flu vaccine for older adults
Healthcare Stocks Fall on Hawkish Fed Turn - Healthcare Roundup | Morningstar
Moderna (MRNA) Shares Rise Following FDA Advisory Committee Approval
Moderna (MRNA) Receives Positive Advisory Committee Vote for Influenza Vaccine
Moderna (MRNA) Receives Positive FDA Advisory Votes for Flu Vaccine Approval
Moderna's mRNA flu vaccine backed by FDA advisers | The Straits Times
Stock Traders Buy High Volume of Moderna Call Options (NASDAQ:MRNA)
Moderna (MRNA) Flu Vaccine Benefits Confirmed by FDA Advisers
Moderna's flu candidate sails through FDA advisory committee in unanimous votes | Fierce Biotech
VRBPAC adcom to vote on Moderna flu vaccine | BioWorld
New mRNA flu vaccine faces scrutiny ahead of key FDA decision
Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny - AOL
Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny - Yahoo News Canada
Table turned, Moderna's high-fi flu shot plays well at adcom | BioWorld
Moderna (MRNA) Soars 11% Ahead of Investor Day
5 Stocks Making Investors Richer
Moderna (NASDAQ:MRNA) Reaches New 1-Year High - Still a Buy? - Zolmax
Best Biotech Stocks To Watch Today - June 17th - Zolmax
Insider Selling: Moderna (NASDAQ:MRNA) President Sells 53,336 Shares of Stock - Daily Political
Moderna (NASDAQ:MRNA) Sets New 12-Month High - Here's Why - Daily Political
Moderna (MRNA) Eyes Manufacturing Facilities in Germany Amid BioNTech Closures
Cynosure Group LLC Makes New Investment in Moderna, Inc. $MRNA - Zolmax
mRNA flu vaccine can activate broad germinal center response | BioWorld
Moderna (MRNA) Climbs 6% as Firm Eyes Launch of 3 Vaccines
Why Is Moderna (MRNA) Stock Soaring Today
10 Stocks With Standout Gains
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Amenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling | Fierce Biotech
Edgewise heads to phase III with solid EDG-7500 data in HCM | BioWorld
Moderna (MRNA) Sees Positive Outlook Ahead of FDA Meeting
Moderna flu shot data may support use in older adults, US FDA staff says
Moderna announces executive changes ahead of potential launches
Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of "Reduce" from Brokerages
Another shot: Moderna flu vaccine re-upped in adcom | BioWorld
Moderna suing Pfizer for patent infringement in COVID-19 vaccine
MRNA: Flu Review And Pipeline Execution Risk Are Expected To Restrain Upside
Fieldview Capital Management LLC Buys Shares of 58,752 Moderna, Inc. $MRNA
The Bull Case For Moderna (MRNA) Could Change Following New Data On Its Personalized Cancer Vaccine
'I worry deeply about bioterrorism': Is Europe sufficiently prepared for another pandemic? | Euronews
Video. Moderna CEO: 'I worry deeply about bioterrorism' | Euronews
Moderna announces new booster to target Omicron
Arbutus Biopharma Corporation (ABUS) Reports Q1 2026 Results
Y Intercept Hong Kong Ltd Invests $13.59 Million in Moderna, Inc. $MRNA - Stock Observer
Moderna (MRNA) Stock Valuation Check After Strong Year To Date Rebound
COVID vaccines: FDA changes guidelines to recommend a single bivalant shot
Moderna: BioNTech is claiming work 'it never did'
Best Biotech Stocks To Keep An Eye On - June 12th - Daily Political
How to Play PBLS Stock After the Parabilis IPO
WINTON GROUP Ltd Invests $800,000 in Moderna, Inc. $MRNA
Parabilis Medicines (PBLS) Surges Over 45% in Debut Following Record IPO
Moderna, Inc. $MRNA Shares Sold by Letko Brosseau & Associates Inc.
Moderna Moves Into Cancer Prevention With UK Lynch Syndrome Trial
Shannon Thyme Klinger Sells 3,471 Shares of Moderna (NASDAQ:MRNA) Stock - Markets Daily
Moderna Inc at Goldman Sachs Healthcare Conference Transcript
Best Biotech Stocks To Add to Your Watchlist - June 9th - Daily Political
Capital World Investors Makes New Investment in Moderna, Inc. $MRNA
Moderna's mRNA-4194 cleared for clinic for Lynch syndrome | BioWorld
Oxford University and Moderna launch trials of vaccine that could prevent cancer
Moderna (NASDAQ:MRNA) Price Target Raised to $34.00 - Zolmax
Havemeyer Place LP Makes New $1.49 Million Investment in Moderna, Inc. $MRNA - Zolmax
Havemeyer Place LP Takes Position in Moderna, Inc. $MRNA
RWC Asset Management LLP Sells 7,065 Shares of Merck & Co., Inc. $MRK - Daily Political
Merck & Co., Inc. $MRK Shares Purchased by O Shaughnessy Asset Management LLC - Daily Political
Merck & Co., Inc. $MRK Stake Cut by ING Groep NV - Markets Daily
ING Groep NV Has $82.79 Million Stock Position in Merck & Co., Inc. $MRK - Zolmax
Norges Bank Makes New Investment in Moderna, Inc. $MRNA
Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Glaukos (GKOS)
PBU The Pension Fund of Early Childhood & Youth Educators Takes Position in Merck & Co., Inc. $MRK - Stock Observer
Is Merck & Co. (MRK) One of the Best Cheap Stocks to Buy for Beginners?
Why Moderna Inc (MRNA) May Struggle to Outperform: A Look at Future Challenges
Moderna Stock: Is MRNA Outperforming the Health Care Sector?
A Look At Moderna (MRNA) Valuation After Positive Five Year Melanoma Vaccine Trial Data
Moderna (MRNA) Climbs 7.5% Ahead of Next Week's Key Updates
Latest news
Show moreRussia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict
Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions
Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis
